Chronic myelogenous leukemia

Results: 283



#Item
21Carbamazepine and rifampin 600 imatinib mesylate generic mg at night. Call your doctor or pharmacist. The benefits of taking this medicine, please read the information but make no warranty as to sleep on an empty stomach

Carbamazepine and rifampin 600 imatinib mesylate generic mg at night. Call your doctor or pharmacist. The benefits of taking this medicine, please read the information but make no warranty as to sleep on an empty stomach

Add to Reading List

Source URL: blog.fabricinteractive.com

Language: English - Date: 2015-07-19 04:29:59
22SPECIAL AUTHORIZATION REQUEST FOR COVERAGE OF HIGH COST CANCER DRUGS (Filgrastim, Capecitabine, Imatinib, Dasatinib, Erolotinib, Sunitinib, Pazopanib, Fludarabine, Sorafenib, Crizotinib, Tretinoin, Nilotinib, Temozolomid

SPECIAL AUTHORIZATION REQUEST FOR COVERAGE OF HIGH COST CANCER DRUGS (Filgrastim, Capecitabine, Imatinib, Dasatinib, Erolotinib, Sunitinib, Pazopanib, Fludarabine, Sorafenib, Crizotinib, Tretinoin, Nilotinib, Temozolomid

Add to Reading List

Source URL: www.gov.pe.ca

Language: English - Date: 2015-04-28 07:44:05
23Chronic Myelogenous Leukemia in Eastern Pennsylvania:

Chronic Myelogenous Leukemia in Eastern Pennsylvania:

Add to Reading List

Source URL: www.atsdr.cdc.gov

Language: English - Date: 2015-05-20 14:40:46
    24

    PDF Document

    Add to Reading List

    Source URL: www.uh.edu

    Language: English - Date: 2014-11-10 18:06:31
    25PUBLIC SUMMARY DOCUMENT Product: Imatinib, tablet, 100 mg and 400 mg (as mesylate), Glivec® Sponsor: Novartis Pharmaceuticals Australia Pty Ltd Date of PBAC Consideration: NovemberPurpose of Application

    PUBLIC SUMMARY DOCUMENT Product: Imatinib, tablet, 100 mg and 400 mg (as mesylate), Glivec® Sponsor: Novartis Pharmaceuticals Australia Pty Ltd Date of PBAC Consideration: NovemberPurpose of Application

    Add to Reading List

    Source URL: www.pbs.gov.au

    Language: English - Date: 2014-10-01 21:56:22
    26HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Tasigna safely and effectively. See full prescribing information for Tasigna. Tasigna® (nilotinib) Capsules Initial

    HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Tasigna safely and effectively. See full prescribing information for Tasigna. Tasigna® (nilotinib) Capsules Initial

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2012-05-02 15:14:28
    27

    PDF Document

    Add to Reading List

    Source URL: www.accessdata.fda.gov

    Language: English - Date: 2011-10-12 15:20:21
    28DISCUSSIONS OF CHRONIC MYELOID LEUKAEMIA AND IMATINIB ADHERENCE WITH PATIENTS AND HEALTH PROFESSIONALS S Wu1, D Chee1, A Ugalde1,2, P Butow3, J F Seymour2, P Schofield2 1The University of Melbourne, Melbourne, Australia

    DISCUSSIONS OF CHRONIC MYELOID LEUKAEMIA AND IMATINIB ADHERENCE WITH PATIENTS AND HEALTH PROFESSIONALS S Wu1, D Chee1, A Ugalde1,2, P Butow3, J F Seymour2, P Schofield2 1The University of Melbourne, Melbourne, Australia

    Add to Reading List

    Source URL: www.supportivecancercarevictoria.org

    Language: English - Date: 2011-08-10 00:52:56
    29EJEMPLO PLAN DE ASIGNATURA:

    EJEMPLO PLAN DE ASIGNATURA:

    Add to Reading List

    Source URL: www.cicancer.org

    Language: English - Date: 2007-07-17 08:21:36
    30Linking cancer genomics with patient management 腫瘤基因組學在癌病治療之應用 Dr Edmond S K Ma Department of Pathology Hong Kong Sanatorium & Hospital

    Linking cancer genomics with patient management 腫瘤基因組學在癌病治療之應用 Dr Edmond S K Ma Department of Pathology Hong Kong Sanatorium & Hospital

    Add to Reading List

    Source URL: www.hkimls.org

    Language: English - Date: 2011-11-27 05:07:36